CytoMed Therapeutics GDTC
NASDAQ GDTC
$1.03 +0.13 (+14.57%)
As of: Aug 21, 2026 · 3:59 PM EDT

CytoMed Therapeutics (GDTC) Property, Plant & Equipment (Net) (2021 - 2025)

CytoMed Therapeutics (GDTC) Property, Plant & Equipment (Net) (2021 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 CytoMed Therapeutics 10.72 Mn 9.11 Mn - 3.33 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.85 Mn
Dec 31, 2025 2.85 Mn
Dec 31, 2024 2.45 Mn
Dec 31, 2024 2.45 Mn
Dec 31, 2023 126,031.78
Dec 31, 2023 126,031.78
Dec 31, 2022 35,976.94
Dec 31, 2022 35,976.94
Dec 31, 2021 301,289.59
Dec 31, 2021 301,289.59